Global Hyperbaric Oxygen Therapy (HBOT) Devices Market to

Seattle, Oct. 19, 2022 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global hyperbaric oxygen therapy (HBOT) devices market is estimated to be valued at US$ 2,891.5 million in 2022 and is expected to exhibit a CAGR of 6.8% during the forecast period (2022-2030).

Key Trends and Analysis of the Global Hyperbaric Oxygen Therapy (HBOT) Devices Market:

Major players operating in the market are focusing on adopting strategies such as product launch and medical certifications which is expected to drive the market growth over the forecast period. For instance, in November 2019, AHA Hyperbarics GmbH,a manufacturer of high pressure hyperbaric systems, announced that they had launched AHA Flex V2 hyperbaric system at the MEDICA, exhibition held in Germany. Moreover, in October 2019, the company received CE certificate from TUV SUD Product Services GmbH, the certification body for its hyperbaric system developed for hyperbaric oxygen therapy.

Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/553

Key Market Takeaways:

The global hyperbaric oxygen therapy (HBOT) devices market is expected to exhibit a CAGR of 6.8% during the forecast period due to adoption of inorganic growth strategies such as partnership. For instance, in June 2018, Sechrist Industries, Inc., a manufacturer of hyperbaric chambers, announced that they had made a partnership with Dartmouth’s Geisel School of Medicine to conduct hyperbaric oxygen therapy (HBOT) devices to Tanzania. Hyperbaric oxygen therapy (HBOT) devices are used for the treatment of decompression sickness

Among product type, Monoplace HBOT devices segment is expected to hold a dominant position over the forecast period. For instance, in September 2020, according to the data published in National Center for Biotecnology Information, the Monoplace chambers are capable in the treatment of decompression illness and facilitate diving operations and in the hospital…